ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 2604

$1.28M Total Retail Price of All Prescriptions

Rank: 12 out of 2604

770 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 770 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 770 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 17,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,039 561 S3 1 1
SIMVASTATIN 908 560 2 2
OMEPRAZOLE 792 512 3 5
LEVOTHYROXINE SODIUM 754 553 4 4
LISINOPRIL 733 513 5 3
FUROSEMIDE 675 527 6 8
METFORMIN HCL 529 280 7 7
METOPROLOL TARTRATE 513 369 8 9
AMLODIPINE BESYLATE 487 404 9 6
TRAMADOL HCL 417 317 10 15
ATENOLOL 399 328 11 11
HYDROCHLOROTHIAZIDE 392 281 12 10
POTASSIUM CHLORIDE 375 340 13 16
GABAPENTIN 351 206 14 12
DONEPEZIL HCL 312 306 15 28
CITALOPRAM HBR 310 227 16 18
LANTUS 286 230 17 40
FENTANYL 259 146 S2 18 48
CARVEDILOL 240 190 19 26
ZOLPIDEM TARTRATE 237 107 20 21
FAMOTIDINE 235 175 21 68
LOSARTAN POTASSIUM 232 220 22 20
ALLOPURINOL 231 190 23 35
CYMBALTA 220 110 24 44
BUMETANIDE 219 187 25 70
MIRTAZAPINE 207 163 26 52
KLOR-CON M20 206 190 27 86
WARFARIN SODIUM 200 109 28 13
CLOPIDOGREL 196 160 29 39
ADVAIR DISKUS 180 134 30 41
TAMSULOSIN HCL 179 120 31 30
RANITIDINE HCL 173 88 32 25
JANTOVEN 171 166 33 118
FLUOXETINE HCL 169 65 34 49
NAMENDA 165 156 35 37
SERTRALINE HCL 163 115 36 23
DIGOXIN 162 118 37 71
ATORVASTATIN CALCIUM 160 124 38 19
POLYETHYLENE GLYCOL 3350 152 97 39 42
PHENYTOIN SODIUM EXTENDED 151 67 40 135
LACTULOSE 151 118 40 108
IBUPROFEN 149 58 42 32
CEPHALEXIN 146 120 43 74
ESCITALOPRAM OXALATE 145 108 44 73
ALENDRONATE SODIUM 143 107 45 29
TRAZODONE HCL 140 73 46 46
MORPHINE SULFATE ER 140 26 S2 46 58
RISPERIDONE 138 88 48 65
ISOSORBIDE MONONITRATE ER 133 131 49 38
NOVOLOG 130 97 50 89
SPIRIVA 124 72 51 45
GLIPIZIDE 124 93 51 51
DIVALPROEX SODIUM 124 119 51 81
PLAVIX 121 98 54 75
PREDNISONE 121 114 54 34
OXYBUTYNIN CHLORIDE ER 119 70 56 110
PROAIR HFA 117 19 57 27
GLIPIZIDE XL 116 82 58 144
CYCLOBENZAPRINE HCL 110 17 R 59 43
AMITRIPTYLINE HCL 107 28 R 60 82
LOVASTATIN 104 66 61 24
PRAVASTATIN SODIUM 102 89 62 14
NEXIUM 99 38 63 53
LEVEMIR 98 76 64 171
HYDRALAZINE HCL 97 93 65 85
QUETIAPINE FUMARATE 97 49 65 66
VENTOLIN HFA 93 36 67 63
CLONIDINE HCL 93 60 67 56
CIPROFLOXACIN HCL 92 70 69 59
MELOXICAM 91 63 70 36
CARBAMAZEPINE 90 35 71 182
ZETIA 89 58 72 94
OXYCODONE HCL-ACETAMINOPHEN 89 23 S2 72 106
HUMALOG 86 67 74 203
ISOSORBIDE MONONITRATE 85 85 75 329
DIOVAN 84 58 76 123
LEVETIRACETAM 82 39 77 96
METOPROLOL SUCCINATE 81 75 78 17
BACLOFEN 81 13 78 101
GEMFIBROZIL 78 34 80 87
CELEBREX 78 34 80 114
LIDOCAINE 76 76 82 152
LIDODERM 76 75 82 80
PANTOPRAZOLE SODIUM 73 33 84 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 46 84 91
CAPTOPRIL 72 50 86 233
INSULIN SYRINGE 72 39 86 109
PREMARIN 72 33 R 86 240
ENALAPRIL MALEATE 69 56 89 50
SPIRONOLACTONE 69 55 89 78
KLOR-CON 10 69 42 89 173
AZITHROMYCIN 69 34 89 33
FLUTICASONE PROPIONATE 68 41 93 31
NIFEDICAL XL 68 59 93 245
PEN NEEDLE 68 49 93 145
PROMETHAZINE HCL 67 41 R 96 88
TOPIRAMATE 67 0 96 143
DILTIAZEM 24HR ER 66 54 98 172
FINASTERIDE 66 66 98 103
PAROXETINE HCL 66 34 98 62
TRIAMTERENE-HCTZ 66 66 98 55
IPRATROPIUM-ALBUTEROL 65 59 102 136
NYSTATIN 65 55 102 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 39 102 22
HYDROXYZINE HCL 63 53 R 105 214
DIOVAN HCT 63 35 105 205
TORSEMIDE 59 43 107 177
ALBUTEROL SULFATE 58 52 108 93
CRESTOR 58 45 108 47
ALPRAZOLAM 58 45 108 119
LANTUS SOLOSTAR 57 26 111 84
FENOFIBRATE 53 29 112 69
ORPHENADRINE CITRATE 53 0 R 112 207
LAMOTRIGINE 52 0 114 185
PROPRANOLOL HCL 52 42 114 154
NITROGLYCERIN PATCH 52 52 114 259
TRIAMCINOLONE ACETONIDE 50 44 117 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.